TGA
An unclear situation
No COVID-19 related medicine shortages yet, regulators say, but reports surface of rural supply issues The TGA is continuing to advise consumers against the stockpiling of medicines, saying that there …
Don’t stockpile meds: TGA
The TGA has issued new advice telling Australians that there’s no need to stockpile medicines, as it could cause access problems for others On Tuesday, the Therapeutic Goods Administration said …
Out of stock
Massive increase in reports of medicine shortages following introduction of mandatory reporting The number of notifications of medicines shortages has jumped massively following the introduction of mandatory reporting in January …
IV infusions under fire
Complaint filed to HCCC and TGA over therapeutic claims for IV therapy made by Australian clinics A number of Australian businesses are making therapeutic claims for IV therapy that a …
Confusion reigns over EpiPen availability
Patient frustration at difficulty accessing EpiPens is understandable – but it’s unfair to call pharmacy “complacent,” says a leading pharmacist Allergy and Anaphylaxis Australia chief executive Maria Said has told …
Check Palexia strips: TGA
A labelling problem has seen Seqirus undertake a product defect correction over one batch of Palexia The TGA has advised consumers and health professionals that in consultation with the TGA, …
Taking the right path
As new laws regarding the prescribing, dispensing and cultivation of medicinal cannabis come into play, pharmacists have an essential role in ensuring patients receive the right advice Since legislative changes …
Caffeine cutback
Tight scheduling restrictions are being imposed on caffeine powders Currently unregulated caffeine powders are to be included as scheduled medicines, after an interim decision announced by the Therapeutic Goods Administration …
Taking responsibility
Scheduling decisions see migraine treatments move to Pharmacist Only status, while liquid paracetamol S2 sales to be restricted from mid-year Proposed medicines scheduling changes will see the migraine treatments Sumatriptan …
Taking advantage of the situation
Warning issued over products claiming to prevent or treat coronavirus The Therapeutic Goods Administration (TGA) has issued a warning to consumers about products that are on sale with claims they …
Opioids under review
TGA flags changes to prescription opioid regulations following consultation The TGA has given notice that changes will be made to the pack sizes, dosage and advice supplied with prescription opioids …
Salbutamol: permission to advertise
The TGA has issued a statement letting Australians know that they do not need to stockpile or over-order supplies of salbutamol inhalers – and that pharmacies can advertise they have …